[1]杨 凯,程英升,杨继金,等.肝脏原发性神经内分泌癌伴肝内多发转移1例并文献复习[J].介入放射学杂志,2015,(04):354-358.
 YANG Kai,CHENG Ying sheng,YANG Ji jin,et al.Primary hepatic neuroendocrine tumor accompanied with multiple hepatic metastases: report of one case with literature review[J].journal interventional radiology,2015,(04):354-358.
点击复制

肝脏原发性神经内分泌癌伴肝内多发转移1例并文献复习()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2015年04期
页码:
354-358
栏目:
临床研究
出版日期:
2015-04-25

文章信息/Info

Title:
Primary hepatic neuroendocrine tumor accompanied with multiple hepatic metastases: report of one case with literature review
作者:
杨 凯 程英升 杨继金 江 旭 郭冀湘
Author(s):
YANG Kai CHENG Ying sheng YANG Ji jin JIANG Xu GUO Ji xiang
Department of Interventional Radiology, Shanghai Sixth People’s Hospital, Shanghai 201306, China
关键词:
肝脏 原发肿瘤 神经内分泌癌 转移 TACE
文献标志码:
A
摘要:
本文报道1例肝脏原发性神经内分泌癌伴肝内多发转移。患者为41岁女性,2010年体检B超发现肝内多发占位,考虑血管瘤,随后定期随访;2013年8月B超发现肝内病灶明显增大,及MRI检查考虑肝内多发血管瘤;CT及MRI图像特点为:富血管肿瘤,边缘清楚,增强后表现为“快进慢出”强化方式,MRI图像表现为多结节灶。穿刺活检病理及免疫组化诊断:倾向于转移性神经内分泌肿瘤;全身检查未见原发灶,我们考虑为肝脏原发性神经内分泌癌伴肝内转移。TACE治疗:奥沙利铂100 mg+明胶海绵颗粒(300~500 μm)1瓶+碘油10 ml,留置导管微泵灌注奥沙利铂100 mg(99 mg/h)。该病临床极为少见;我们复习文献,对该病的发病特点、鉴别诊断、治疗方法、预后判断作初步探讨。

参考文献/References:

[1] 陈璐璐. 胃肠胰神经内分泌肿瘤诊治进展[J]. 中国实用内科杂志, 2006, 26: 1760 1762.
[2] Kaya G, Pasche C, Osterheld MC, et al. Primary neuroendocrine carcinoma of the liver: an autopsy case[J]. Pathol Int, 2001, 51: 874 878.
[3] 许加刚, 李 伟, 李 玲. 47例原发性肝神经内分泌癌的临床分析[J]. 中国现代医生, 2013, 51: 61 63.
[4] Akahori T, Sho M, Tanaka T, et al. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors[J]. Anticancer Res, 2013, 33: 3355 3358.
[5] 刘冬娟, 郭金明, 李艳杰, 等. 肝神经内分泌癌超微结构的观察与分析[J]. 中国医科大学学报, 2003, 32: 217 218.
[6] 朱世华, 张云山, 贺 声, 等. 原发性肝、 胆囊神经内分泌癌的影像学表现[J]. 中华放射学杂志, 2003, 37: 1143 1147.
[7] 刘志刚, 钱叶本, 耿小平, 等. 肝血管瘤的诊断和治疗(附47例报告)[J]. 中国医师进修杂志, 2007, 30: 15 18.
[8] Bajetta E, Ferrari L, Procopio G, et al. Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours[J]. Ann Oncol, 2002, 13: 614 621.
[9] Moertel CG, Kvols LK, O’connell MJ, et al. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms[J]. Cancer, 1991, 68: 227 232.
[10] Kouvaraki MA, Ajani JA, Hoff P, et al. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas[J]. J Clin Oncol, 2004, 22: 4762 4771.
[11] Oberg K. Chemotherapy and biotherapy in neuroendocrine tumors[J]. Curr Opin Oncol, 1993, 5: 110 120.
[12] Terris B, Scoazec JY, Rubbia L, et al. Expression of vascular endothelial growth factor in digestive neuroendocrine tumours[J]. Histopathology, 1998, 32: 133 138.
[13] Pavel ME, Hassler G, Baum U, et al. Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas[J]. Clin Endocrinol (Oxf), 2005, 62: 434 443.
[14] Yao J, C NG, Hoff P, et al. Improved progression free survival and rapid sustained decreased carcinoid treated with bevacizumab[J]. J Clin Oncol, 2005, 23: Suppl 4007.
[15] Strosberg JR, Kvols LK. A review of the current clinical trials for gastroentero pancreatic neuroendocrine tumours[J]. Expert Opin Investig Drugs, 2007, 16: 219 224.
[16] Fenwick SW, Wyatt JI, Toogood GJ, et al. Hepatic resection and transplantation for primary carcinoid tumors of the liver[J]. Ann Surg, 2004, 239: 210 219.
[17] Yau T, Yao TJ, Chan P, et al. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization[J]. Cancer, 2009, 115: 5507 5515.

相似文献/References:

[1]刘德兴,吴林,马晓静,等.肝脏穿刺腔道封闭止血方法的临床研究[J].介入放射学杂志,2008,(10):739.
 LIU Dexing,WU Lin,MA Xiaojing,et al.Clinical research on hemostasia for occluding puncture channel of liver[J].journal interventional radiology,2008,(04):739.
[2]姜永能,胡继红,邬明,等.肝脏局灶性结节增生的DSA和MRI 诊断[J].介入放射学杂志,2010,(07):531.
 JIANG Yongneng,HU Jihong,WU Ming,et al.DSA and MRI diagnosis of hepatic focal nodular hyperplasia[J].journal interventional radiology,2010,(04):531.
[3]李伟雄,裴云,李荣富,等.肝脏海绵状血管瘤的介入治疗 附32例报告[J].介入放射学杂志,1997,(01):24.
[4]程永德.CT导向下酒精注射骨骼转移灶[J].介入放射学杂志,1995,(03):133.
[5]曹贵文,王滨,孙业全,等.经胆管 192Ir 内照射对胆管 、 肝脏放射损伤的实验研究[J].介入放射学杂志,2007,(01):53.
 CAO Gui-wen,WANG Bin,SUN Ye-quan,et al.The experimental study of radiation injury on bile duct and liver tissue[J].journal interventional radiology,2007,(04):53.
[6]王朝华,谢晓东,闫庆,等.经导管栓塞治疗肝脏外伤出血[J].介入放射学杂志,2007,(04):226.
 WANG Chao-hua,XIE Xiao-dong,YAN Qing,et al.Transcatheter arterial embolization for traumatic hepatic hemorrhage[J].journal interventional radiology,2007,(04):226.
[7]秦永福,宁路江,齐颖,等.原发性肝癌合并门脉癌栓的经导管碘油化疗栓塞[J].介入放射学杂志,1996,(04):223.
[8]袁敏,杨继金,沈辉,等.肝动脉栓塞联合瘤体内博莱霉素注射治疗少血供性肝血管瘤[J].介入放射学杂志,2007,(06):387.
 YUAN Min,YANG Ji-jin,SHEN Hui,et al.Treatment of hypovascular hepatic cavernous hemangiomas by percutaneous intratumoral bleomycin injection after selective hepatic arterial embolization[J].journal interventional radiology,2007,(04):387.
[9]张恩全,陈伟,陆明,等.膈顶部肝脏病变CT引导下切割针活检的准确性和安全性[J].介入放射学杂志,2007,(12):838.
 ZHANG En-quan,CHEN Wei,LU Ming,et al.The accuracy and safety of CT guided cutting needle biopsy for the hepatic lesions near the diaphragmatic dome[J].journal interventional radiology,2007,(04):838.
[10]欧阳墉,程永德,张学军,等.肝海绵状血管瘤病理属性及治疗 [J].介入放射学杂志,2015,(11):933.
 OUYANG Yong,CHENG Yong- de,ZHANG Xue- jun,et al.The pathological category and the treatment of hepatic cavernous hemangiomas Department of Interventional Radiology[J].journal interventional radiology,2015,(04):933.

备注/Memo

备注/Memo:
(收稿日期:2014-07-29)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2015-04-27